• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Embla Medical

26.80 DKK

+0.37 %

Less than 1K followers

EMBLA

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
+0.37 %
+2.10 %
-2.90 %
-17.54 %
-19.76 %
-21.64 %
-14.10 %
-41.16 %
+387.27 %

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.

Read more
Market cap
11.47B DKK
Turnover
2.07M DKK
Revenue
5.91B
EBIT %
13.49 %
P/E
21.5
Dividend yield-%
-
Coverage
Disclaimer
Michael Friis
Michael Friis

Head of Equities

Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
21.7
2026

Interim report Q2'26

20.10
2026

Interim report Q3'26

2.2
2027

Annual report '26

Regulatory press release5 hours ago

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release6/8/2026, 3:00 PM

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release6/1/2026, 3:00 PM

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/26/2026, 3:00 PM

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release5/18/2026, 3:00 PM

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release5/11/2026, 3:00 PM

Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release5/4/2026, 3:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Embla Medical: Recording of Q1 2026 results presentation
Analyst Comment4/29/2026, 5:00 AM by
Michael Friis

Embla Medical: Recording of Q1 2026 results presentation

Yesterday, Embla Medical’s CEO, Sveinn Sölvason, presented the Q1 2026 results and outlined the key drivers behind that 2026 guidance was reiterated despite a slow start to the year in the first quarter.

Embla Medical
Embla Medical – Presentation of the Q1 2026 Interim Report
Webcast4/28/2026, 8:30 AM

Embla Medical – Presentation of the Q1 2026 Interim Report

Embla Medical will publish its interim report for Q1 2026 on 28 April 2026. At 10:30 CET, CEO Sveinn Sölvason will present the results, comment on the most important developments in the business, and provide an update on the company's outlook for 2026, followed by a live online Q&A session.

Embla Medical
HCA Morgenbørs 28/04 - Tro på en hurtig fredsløsning ramt
Video4/28/2026, 7:16 AM by
Michael Friis

HCA Morgenbørs 28/04 - Tro på en hurtig fredsløsning ramt

I dagens Morgenbørs ser vi et marked uden retning fra morgenstunden, tro på en hurtig fredsløsning ramt. Herhjemme er der fokus på Zealand, Alm Brand, DS Norden, Embla

D/S NordenTormZealand PharmaAlm. BrandEmbla Medical
Dagens aktienyheder 28/04-2026: Embla Medical og NORDEN
Analyst Comment4/28/2026, 6:52 AM by
Victor Skriver

Dagens aktienyheder 28/04-2026: Embla Medical og NORDEN

Dagens aktienyheder 28/04-2026: Embla Medical og NORDEN

D/S NordenEmbla Medical
Regulatory press release4/28/2026, 5:00 AM

Embla Medical hf.: Embla Medical hf: Interim Report Q1 2026

Embla Medical
Regulatory press release4/27/2026, 3:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release4/20/2026, 3:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Press release4/20/2026, 6:00 AM

Embla Medical hf.: Embla Medical hf: Conference call details for Q1 2026

Embla Medical
Regulatory press release4/13/2026, 3:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release4/7/2026, 3:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release3/30/2026, 3:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release3/23/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release3/16/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical